Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-26T09:40:15.939Z Has data issue: false hasContentIssue false
  • English
  • Français

Incidence and Epidemiology of Methicillin-Resistant Staphylococcus aureus Infection in a Saudi Arabian Hospital, 1999-2003

Published online by Cambridge University Press:  21 June 2016

Jaffar A. Al-Tawfiq
Jaffar A. Al-Tawfiq*
Affiliation:
Internal Medicine Services Division, Dhahran Health Center, Saudi Aramco Medical Services Organization, Saudi Aramco, Dhahran, Saudi Arabia
*
PO Box 76, Room A-420B, Building 61, Dhahran Health Center, Saudi Aramco, Dhahran 31311, Saudi Arabia, (jaffar.tawfiq@aramco.com)
Get access Rights & Permissions [Opens in a new window]

Abstract

During 1999-2003 in a Saudi Arabian Hospital, methicillin-resistant Staphylococcus aureus constituted 6% of all S. aureus isolates; the proportion had increased from 2% in 1999, to 9.7% in 2002, to 8% in 2003. Of all MRSA isolates, 62% represented community-acquired infection, 20.4% represented healthcare-associated infection, and 17.6% represented nosocomial infection. The proportion of community-acquired isolates increased from 41.7% in 1999 to 66.6% in 2002, and the proportion representing nosocomial infection decreased from 33% in 1999 to 19% in 2003. Isolates representing nosocomial infection showed higher rates of resistance to ciprofloxacin (76.6%), clindamycin (76.6%), erythromycin (68%) and trimethoprim-sulfamethoxazole (68%) than did isolates in the other categories (P<.001).

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 10 , October 2006 , pp. 1137 - 1139
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Barrett, FF, McGehee, RF Jr, Finland, M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital: bacteriologie and epidemiologic observations. N Engl J Med 1968; 279:441–448.Google Scholar
2. Boyce, JM. Methicillin-resistant Staphylococcus aureus: detection, epidemiology, and control measures. Infect Dis Clin North Am 1989; 3:901–913.Google Scholar
3. Madani, TA, Al-Abdullah, NA, Al-Sanousi, AA, Ghabrah, TM, Afandi, SZ, Bajunid, HA. Methicillin-resistant Staphylococcus aureus in two tertiary-care centers in Jeddah, Saudi Arabia. Infect Control Hosp Epidemiol 2001; 22:211–216.CrossRefGoogle ScholarPubMed
4. Centers for Disease Control and Prevention. Community-acquired methicillin-resistant Staphylococcus aureus infections—Michigan. MMWR Morb Mortal Wkly Rep 1981; 30:185–187.Google Scholar
5. Salgado, CD, Farr, BM, Calfee, DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36:131–139.Google Scholar
6. Herold, B, Immergluck, L, Maranan, M, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593–598.Google Scholar
7. Hussain, FM, Boyle-Vavra, S, Daum, RS. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatr Infect Dis J 2001; 20:763–767.Google Scholar
8. Herold, BC, Immergluck, LC, Maranan, MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593–598.Google Scholar
9. NCCLS. Performance Standards for Antimicrobial Disk Susceptibility Tests: Ninth Information Supplement. Wayne, PA: NCCLS; 1999.Google Scholar
10. Fridkin, SK, Hageman, JC, Morrison, M, et al.; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352:1436–1444.Google Scholar
11. Naimi, TS, LeDell, KH, Como-Sabetti, K, et al. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290:2976–2984.Google Scholar
12. Vandenbroucke-Grauls, C. Management of methicillin-resistant Staphylococcus aureus in The Netherlands. Rev Med Microbiol 1998; 9:109–116.Google Scholar
13. Zaman, R, Dibb, WL. Methicillin resistant Staphylococcus aureus (MRSA) isolated in Saudi Arabia: epidemiology and antimicrobial resistance patterns. J Hosp Infect 1994; 26:297–300.Google Scholar
14. Austin, TW, Austin, MA, McAlear, DE, et al. MRSA prevalence in a teaching hospital in western Saudi Arabia. Saudi Med J 2003; 24:1313–1316.Google Scholar
15. Bukharie, HA, Abdelhadi, MS. The epidemiology of methicillin-resistant Staphylococcus aureus at a Saudi university hospital. Microb Drug Resist 2001; 7:413–416.Google Scholar
16. Bukharie, HA, Abdelhadi, MS, Saeed, IA, Rubaish, AM, Larbi, EB. Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagn Microbiol Infect Dis 2001; 40:1–4.Google Scholar
17. Chen, CJ, Huang, YC, Chiu, CH, Su, LH, Lin, TY. Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Pediatr Infect Dis 2005; 24:40–45.Google Scholar
18. Eady, EA, Cove, JH. Staphylococcal resistance revisited: community-acquired methicillin-resistant Staphylococcus aureus—an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 2003; 16:103–124.Google Scholar
19. Zetola, N, Francis, JS, Nuermberger, EL, Bishai, WR. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005; 5:275–286.Google Scholar